Q25802 AF NFT

DNA-directed RNA polymerase subunit beta''

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigifeagltacqcyyfvsfbxpdbz5qla7o7kvryptlwhimzvzucs7a6e/metadata.json
IPFS of structure file: 
bafybeidt6r6yjarhx4tseug7zqsj4mjsgtnblm3xzk46eabmimjjnw2wye/AF-Q25802-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x1ED4a68B4011314730adE976b56Ad4cA21b54dcD
First NFT owner address (bech32): 
genesis1rm22dz6qzyc5wv9da9mt26k5egsm2nwdw6hzk8
Current NFT ID #388086 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388086
Accession (UniProt):
Q25802
Name::
DNA-directed RNA polymerase subunit beta''
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q25802 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q25802|RPOC2_PLAF7 DNA-directed RNA polymerase subunit beta'' OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=rpoC2 PE=3 SV=2 MYFYFFNKYNLKILEKKLLIIFKYNISFKILHELLYLGYEYSFLYNYSLNIKDFSNFIYLLILYKNKINNIYNNKYYEIKNNYINVFLNNYYYLKVINKIQGILNNNLYNKINPIYSNLFLFFNNKIKIKYSQLQQLIGYKGYISNIKGMIYEKPVINNYINELNIYEYILSCYGSKKGIIDTALKTADSGYLTKRLINITSNFIIKELNCKSPFILKYILNMDIYGNIILPLNILRFKILQNNILNLNNGTFIYTKNTYITKYILNKLLNLYNRRNIYLNIKSVYLCNIYNNICNTCLNYKQLYKYNLGQHIGVISSEAISEPSTQMVLRTFHASSILKDKFNFNKYLIYKIYLYKLNINKIFKLIINFKKYINIKFNLIFLMNKILYNYNNILFEYKYILQNQYIKCNFIYNSISKNFKYNLNNIIIKYLNNVIKYYNYSNIQLLIKNIHNKWILYNIYTYYLYYYHIKFYNLYNKGIILNNNNNKYNVIYFLINYFNLFSNYYYKIYNNNYNFINSNYYFKMNFILKNFNNIQILNKLFYVNNIFIYYKYEKKLFIYLNIINNIIIKKYLNFYKYTYNKLFFIKKYNNFLYLYEIFKYNWYKYLLLNNKYNLYIIYNNYIKYLYKYNININLYFIKNLFYNNNNFIHNHIIYKNNYYIYNNNMNLYQYNKNILINNNLLYNKLFYNYINNNIYNLYLNDITIGLQSINIIFENKNIKDNIFFISNNIYVIFYIKYYNYLNNIIYIYNICNKYNINHYKYKLNFYSYIFEDISSILYSGYSLHTEFYSINKNLKYYFRFLLKSINIYQATKSSYIYVYNILIESILKQYSYQNIYLPSIYFELIIKKMLSCIKIISNNFKIFKYNDIISLQLINIINYSLNLNKHYIYKYEPIILGITKSILANSGFLTNISFQNTFKIISLNILNNKIDWLIDIKSKIILTDLLPVGNGWYRYLVN